Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823847 · ClinicalTrials.gov registry record · Early Phase 1
Non Invasive Oral Cancer Screening Among HIV Infected Individuals
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
NCT02823847: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02823847 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823847, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.
Interventions
- BEHAVIORAL Self-Help Materials
- BEHAVIORAL Screening Interview
- DEVICE Carbon Monoxide Test
- PROCEDURE Visual Oral Screening Examination
- PROCEDURE Direct Fluorescent Oral Visualization Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2021-07-26 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02823847
The ClinicalTrials.gov registry entry for NCT02823847 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Self-Help Materials is the first listed.
NCT02823847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02823847 about?
NCT02823847 is a clinical study titled "Non Invasive Oral Cancer Screening Among HIV Infected Individuals". The goal of this clinical research study is to learn how a new method for performing oral (mouth) exams can help doctors check for suspicious lesions (called premalignant and malignant oral lesions \[PMOL\]) in the mouth of HIV-infected smokers.
What is the current status of trial NCT02823847?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2016-06-30. Estimated completion is 2021-07-26.
What interventions are being tested in trial NCT02823847?
The interventions under investigation include: Self-Help Materials (BEHAVIORAL), Screening Interview (BEHAVIORAL), Carbon Monoxide Test (DEVICE), Visual Oral Screening Examination (PROCEDURE), Direct Fluorescent Oral Visualization Examination (PROCEDURE).
Who is sponsoring clinical trial NCT02823847?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.